The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the
annual general meeting to be held on Thursday 14 May 2020, at 10.00 at Baker & McKenzie
Advokatbyrå's premises at Vasagatan 7 in Stockholm.
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.